Monotherapy with infusion therapies - useful or not?
Infusion pump-based therapies are an effective treatment option for patients with advanced Parkinson´s disease. Achieving monotherapy with infusion-based therapies could simplify the treatment regimen, provide better medication adherence, reduce adverse events and drug interactions. This review pres...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | JOURNAL OF NEURAL TRANSMISSION
|
| Tárgyszavak: | |
| doi: | 10.1007/s00702-024-02801-2 |
| mtmt: | 35138307 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/34260 |
| LEADER | 01967nab a2200253 i 4500 | ||
|---|---|---|---|
| 001 | publ34260 | ||
| 005 | 20240722105135.0 | ||
| 008 | 240722s2024 hu o 000 eng d | ||
| 022 | |a 0300-9564 | ||
| 024 | 7 | |a 10.1007/s00702-024-02801-2 |2 doi | |
| 024 | 7 | |a 35138307 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rožanković Petra Bago | |
| 245 | 1 | 0 | |a Monotherapy with infusion therapies - useful or not? |h [elektronikus dokumentum] / |c Rožanković Petra Bago |
| 260 | |c 2024 | ||
| 490 | 0 | |a JOURNAL OF NEURAL TRANSMISSION | |
| 520 | 3 | |a Infusion pump-based therapies are an effective treatment option for patients with advanced Parkinson´s disease. Achieving monotherapy with infusion-based therapies could simplify the treatment regimen, provide better medication adherence, reduce adverse events and drug interactions. This review presents the literature data on the efficacy, safety, and achievability of monotherapy with all available infusion-based therapies, including apomorphine, levodopa-carbidopa-intestinal gel (LCIG), levodopa-entacapone-carbidopa intestinal gel (LECIG), and foslevodopa-foscarbidopa (LDp/CDp). In summary, monotherapy is achievable and effective in most patients on intestinal levodopa infusion therapy and in some patients on apomorphine infusion. There is a need for further investigation of monotherapy compared to polytherapy, especially in new pump treatment options (LECIG and LDp/CDp). Future research should reveal which patients on infusion-based therapies could benefit from monotherapy, including identification of potential baseline predictors of achieving monotherapy in patients treated with specific infusion-based therapies. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Johansson Anders |e aut |
| 700 | 0 | 1 | |a Klivényi Péter |e aut |
| 700 | 0 | 1 | |a Milanov Ivan |e aut |
| 700 | 0 | 1 | |a Odin Per |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/34260/1/s00702-024-02801-2.pdf |z Dokumentum-elérés |